Compare · FAMI vs LFCR
FAMI vs LFCR
Side-by-side comparison of Farmmi Inc. (FAMI) and Lifecore Biomedical Inc. (LFCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- FAMI operates in Consumer Staples, while LFCR operates in Health Care - the two are in different parts of the market.
- LFCR is the larger of the two at $242.6M, about 71.5x FAMI ($3.4M).
- LFCR has hit the wire 7 times in the past 4 weeks while FAMI has been quiet.
- LFCR has more recent analyst coverage (6 ratings vs 0 for FAMI).
- Company
- Farmmi Inc.
- Lifecore Biomedical Inc.
- Price
- -
- -
- Market cap
- $3.4M
- $242.6M
- 1M return
- +1.52%
- -
- 1Y return
- -92.53%
- -
- Industry
- Packaged Foods
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 6
Farmmi Inc.
Farmmi, Inc., together with its subsidiaries, processes and sells agricultural products in China, the United States, Japan, Canada, Europe, Korea, and the Middle East. The company offers shiitake and Mu Er mushrooms; and other edible fungi products, including bamboo fungi, agrocybe aegerila, pleurotus eryngii, grifola frondosa, coprinus comatus, and hericium erinaceus. It also operates Farmmi Jicai, an online store that sells edible fungi products under Forasen and Farmmi Liangpin brands. In addition, the company exports dried whole and sliced shiitake mushrooms, and dried black fungus to Israel. It offers its products to restaurants, cafeterias, and local specialty stores, as well as through distributors. Farmmi, Inc. was incorporated in 2015 and is headquartered in Lishui, China.
Latest FAMI
- SEC Form 6-K filed by Farmmi Inc.
- SEC Form 6-K filed by Farmmi Inc.
- Farmmi Receives NASDAQ Notification Regarding Minimum Bid Requirements
- Farmmi, Inc. Proposes to Acquire Brazilian Agricultural Supply Chain Company
- SEC Form 6-K filed by Farmmi Inc.
- Farmmi, Inc. Announces Closing of $3.0 Million Underwritten Public Offering
- SEC Form 424B5 filed by Farmmi Inc.
- Farmmi, Inc. Announces Pricing of $3.0 Million Underwritten Public Offering
- SEC Form 424B5 filed by Farmmi Inc.
- Farmmi, Inc. Announces Launch of Proposed Public Offering
Latest LFCR
- SEC Form DEFA14A filed by Lifecore Biomedical Inc.
- Lifecore Biomedical Inc. filed SEC Form 8-K: Other Events
- SEC Form 10-Q filed by Lifecore Biomedical Inc.
- Lifecore Biomedical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
- SEC Form PREM14A filed by Lifecore Biomedical Inc.
- SEC Form 8-K filed by Lifecore Biomedical Inc.
- Lifecore Biomedical to Participate at Upcoming Industry Conferences
- Lifecore Biomedical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
- SEC Form DEFA14A filed by Lifecore Biomedical Inc.